Gene Expression Technologies Show Promise As An Aid To Breast Cancer Decision Making

Gene expression technologies show “considerable potential for improving prognostic and therapeutic prediction” in early-stage breast cancer concludes a systematic review, published in the Annals of Internal Medicine, of the three currently available commercial assays. “But more needs to be learned about the extent of that improvement….. and how they are best incorporated into decision making about current breast cancer treatment,” write the study’s authors Steven N.

More: continued here

Filed under: Breast Cancer on February 26th, 2008